|
|
||||||||
J Thorac Cardiovasc Surg 2002;123:648-654
© 2002 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease (CHD) |
From the Departments of Anesthesiology,a Cardiovascular Surgery,b and Pediatric Cardiology,c Deutsches Herzzentrum München, München, Germany
Received for publication May 29, 2001. Revisions requested July 5, 2001; revisions received July 24, 2001. Accepted for publication Aug 31, 2001. Address for reprints: Peter Tassani, MD, Department of Anesthesiology, Deutsches Herzzentrum München, Lazarettstr 36, 80636 München, Germany (E-mail: tassani{at}dhm.mhn.de).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Also, the immune response to CPB has been the subject of previous investigations.
12 Although it is well known that CPB also induces the release of a variety of inflammatory mediators in pediatric patients,
13 the effect of DHCA and LF-CPB on systemic inflammatory response in infants has not yet been investigated systematically. The aim of our study was to compare these 2 strategies in respect to their supposed effect on the activation of the complement system represented by changes of anaphylatoxin C3a and the proinflammatory mediators interleukin 6 and interleukin 8.
| Methods |
|---|
|
|
|---|
Infants underwent spontaneous cooling because of the cool ambient temperature of the operating room during induction of anesthesia. Using a cooling blanket (Blanketrol II; Cincinnati Sub Zero, Cincinnati, Ohio), a rectal temperature of 32°C to 33°C was reached at the commencement of CPB.
The pump was primed with 250 mL of packed cells and 250 mL of fresh-frozen plasma, to which 100 mL of lactated Ringer's solution, 1000 IU of heparin, 2.5 mL/kg sodium bicarbonate 4.2%, and 3 mL/kg mannitol 20% were added. After systemic anticoagulation with 3 mg/kg heparin and administration of 1 mg/kg dexamethasone, CPB was instituted at a flow rate of 2.4 L · min-1 · m-2. During rewarming, ultrafiltration was performed for a maximum of 20 minutes or until the level of the venous reservoir was at the lower level. After weaning from CPB, all patients underwent modified ultrafiltration for the same time period.
DHCA group
In patients in the DHCA group, an arterial cannula was placed in the ascending aorta; for venous return, one cannula was inserted in the right atrium. Then systemic hypothermia was induced until an esophageal temperature of 16°C and a rectal temperature of 18°C were achieved. Before the start of DHCA, the CPB flow rate was decreased by half. After crossclamping the aorta, 50 mL/kg cold crystalloid cardioplegic solution (Bretschneider, Custodiol; Köhler Chemie, Alsbach-Hähnlein, Germany) was infused through the aortic root. Alpha-stat acid-base management was used during hypothermic CPB to maintain an uncorrected arterial carbon dioxide tension of 40 mm Hg. After the above-mentioned temperatures had been achieved, circulatory arrest was begun. After correction of the congenital malformation, CPB was started at 1.2 L · min-1·m-2, and a total flow of 2.4 L · min-1 · m-2 was maintained during rewarming at a rectal temperature of more than 28°C. The difference between the perfusate and rectal temperature was less than 10°C during rewarming.
LF group
Instead of using one venous cannula in the right atrium, patients in the LF group underwent bicaval cannulation. Cooling was performed until rectal temperature was less than 24°C. A stable flow of 1.2 L · min-1 · m-2 was maintained thereafter during the period of intracardiac correction. After crossclamping the aorta, 50 mL/kg cold crystalloid cardioplegic solution (Bretschneider, Custodiol, Köhler Chemie) was infused through the aortic root. Alpha-stat acid-base management was used during hypothermic CPB to maintain an uncorrected arterial carbon dioxide tension of 40 mm Hg. During rewarming, the flow rate was gradually increased to 2.4 L · min-1 · m-2.
Samples and measurements
Blood samples were obtained, and hemodynamic measurements were performed at the following time points: (1) before the operation; (2) during CPB during rewarming and after DHCA in the DHCA group (30°C rectal temperature); (3) 30 minutes after CPB; (4) 2 hours after CPB; (5) 4 hours after CPB; and (6) 24 hours after CPB.
Anaphylatoxin C3a was measured with a radioimmunoassay (Amersham, Little Chalfont, England), and interleukin 6 and interleukin 8 levels were measured with a solid-phase, 2-site chemiluminescent enzyme immunometric assay (Immulite System; Diagnostic Products Corp, Los Angeles, Calif).
A radiologic index was calculated as the ratio of the dimension of soft tissues measured at the height of the eighth rib to the diameter of the eighth rib measured at the midclavicular line to quantify the edema of the soft tissues.
14 Measurements were performed on the preoperative chest radiographic film and on the first and second postoperative day.
Statistics
Before the study, a power calculation for a 20% difference in postoperative weight gain with a probability of type
error of 5% and a probability of type ß error of 20% yielded a sample size of 11 patients for each group. The group means were compared with the Mann-Whitney U test (nonparametric). Results are presented as means ± SEM. Differences were considered to be statistically significant when the probability of type
error was less than 5%.
| Results |
|---|
|
|
|---|
|
Inflammatory response
Inflammatory response data are shown in Figures 1 through 3. Figure 1
shows the significant lower concentration of anaphylatoxin 3a in DHCA patients versus that in LF patients (3751 ± 388 vs 5761 ± 1688 ng/mL during CPB while rewarming the patient). The concentration of interleukin 6 shows a tendency to be lower in DHCA patients versus that seen in LF patients at 0.5 and 2 hours after CPB. The concentration of interleukin 8 was significantly lower in DHCA patients (64 ± 12 vs 116 ± 44 pg/mL, Figure 3
).
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Excellent clinical results have been published on a series of 120 Fontan or Fontan-like operations with the DHCA technique.
15 The postoperative morbidity in respect to the development of pleural effusions and ascites was extremely low in this group of patients. It is conceivable that reduced systemic inflammatory response with DHCA is one reason for the smooth postoperative course of these patients; inflammatory mediators have, however, not been measured.
15
Therefore, this study investigated the inflammatory response with the 2 different perfusion techniques: DHCA versus continuous low-flow perfusion. Levels of anaphylatoxin C3a and the proinflammatory chemokine interleukin 8 were found to be significantly lower in patients after DHCA compared with in patients after LF-CPB. Proinflammatory interleukin 6 showed a tendency to be lower in patients after DHCA.
There are 2 main reasons potentially leading to reduced inflammatory response after DHCA: (1) shorter duration of CPB and (2) lower temperature.
Duration of CPB was significantly lower in patients after DHCA compared with patients after LF-CPB. A correlation between duration of CPB and inflammatory response has already been reported.
16,17 The second factor might be the lower temperature (18°C) in the DHCA group compared with that in the LF group (24°C). However, the effect of temperature on inflammatory response is not a linear relationship. It is already known that tepid temperature during CPB (32°C-34°C) is associated with reduced systemic inflammatory response compared with that during normothermic CPB.
18 A recently published investigation in 24 pigs with normothermia (37°C), moderate hypothermia (28°C), or deep hypothermia (20°C) showed that moderate hypothermia is associated with lower concentrations of proinflammatory mediators and higher concentrations of anti-inflammatory mediators compared with concentrations in the other 2 groups.
19 Moderate hypothermia was associated with the lowest histologic organ damage score, and normothermia was associated with the highest score.
19 Therefore, higher levels of inflammatory mediators had to be expected in the DHCA group (18°C) compared with those in the LF-CPB group (24°C), which is in contrast to the findings of the present investigation.
Another factor potentially influencing the inflammatory reaction is the degree of the hypoxemia in these patients. In cyanotic patients inflammatory response was already stimulated before the operation.
20 In our population there are 2 patients in the DHCA group with a cyanotic lesion and 5 in the LF group. However, the patients with transposition of the great arteries had a balloon atrioseptostomy before the operation, and the oxygen saturation was more than 85% in every one of the patients. In addition, no differences in the baseline levels of either mediator could be detected between the 2 study groups. In regard to preexisting congestive heart failure, there was one patient in the DHCA group who received digitoxin; no patients received catecholamines, however.
In the present investigation clinical parameters, such as mean arterial pressure, postoperative weight gain, and a radiologic soft-tissue index, also seem to suggest a superior postoperative course after DHCA compared with after LF-CPB. The higher arterial pressure after CPB in DHCA patients compared with that in LF patients may be the result of reduced vasodilation caused by reduced inflammatory response (C3a and interleukin 8). This is in concordance with another investigation, in which the incidence of vasodilation necessitating vasopressor support was 2-fold higher in a group of patients undergoing normothermic CPB compared with in patients undergoing hypothermic CPB.
18 Reduced weight gain postoperatively may reflect reduced capillary leakage, which has been shown to be associated with the inflammatory response syndrome.
14 However, the transcapillary escape rate of protein has to be determined to really measure capillary leakage, which has not been done in this investigation. Reduced weight gain after CPB in patients after DHCA may be the result of the shorter CPB duration in addition to the reduced inflammatory response. Patients who underwent a Fontan operation are extremely sensitive to fluid accumulation and fluid shifts after CPB. Therefore, it seems obvious that DHCA and also modified ultrafiltration lead to a superior clinical outcome.
15 A significantly higher survival rate has been reported recently by Mosca and associates,
21 who used DHCA in 100 consecutive patients with hypoplastic left heart syndrome. Although ultrafiltration raises colloid osmotic pressure and hematocrit levels, a significant reduction of inflammatory mediators could not be demonstrated.
22
The results of the present investigation are in line with those of the Boston Circulatory Arrest Study, in which patients had significantly less weight gain after DHCA.
7,23,24 Ischemia and subsequent reperfusion of isolated organs lead to significant production of inflammatory mediators in the respective organs. This has been proven for the heart
25 and also for the lungs.
26,27 In contrast to these results, a similar effect does not play a decisive role for the whole body in the case of DHCA, according to the data of our study.
Although nonneurologic outcome in the arterial switch operation did not differ between those receiving the DHCA and LF-CPB techniques,
8 there is always concern about neurologic deficits after use of DHCA. Profound hypothermia (18°C) reduces systemic metabolism to 16% of control levels, but cerebral metabolism is only reduced to 32% to 40% of control levels in an animal model.
28 Children show developmental delays on specific neuropsychologic testing after either LF-CPB or DHCA. Up to 10% of infants have been shown to exhibit seizures after DHCA.
29 Furthermore, a linear relationship between the duration of DHCA and IQ has been suggested.
30 No attempt was made, however, to investigate the neurologic sequelae of the 2 different perfusion techniques in the present investigation.
Inflammatory response is reduced by the use of DHCA compared with the reduction seen with low-flow perfusion. A shorter duration of CPB and a lower body temperature may contribute to this finding, whereas ischemia and reperfusion of the whole body do not seem to play a major role.
| Discussion |
|---|
|
|
|---|
Dr Tassani. Thank you, Professor Ziemer, for this very good comment. According to our clinical practice, surgical correction is performed under the conditions of deep hypothermia combined with low-flow perfusion or total circulatory arrest. Reducing flow under hypothermic conditions ensures sufficient oxygen supply and provides better surgical conditions for corrections. We never practice full-flow perfusion combined with deep hypothermia. But I have to mention that cooling and rewarming was achieved in both groups with full-flow perfusion rates. In the LF group pump flow was reduced by 50% after 24°C was reached.
Dr Pedro J. del Nido (Boston, Mass). One important variable that you did not mention was hematocrit levels. If you have a significant amount of hemodilution and you keep a baby on bypass for an additional 40 or 50 minutes, I think it is very likely that this could easily explain the third-space increase. Could you tell us what the hematocrit level was in both groups?
Dr Tassani. During extracorporeal circulation, the hemoglobin value was about 7 to 8 g/dL, corresponding to the measured hematocrit of about 20% to 25%. Pump priming was quite similar in both groups. I have not presented the data, but we found no statistical differences between the groups.
Dr del Nido. I suspect that if you maintain the hematocrit at 25% or close to 30%, and in fact there are several clinical centers that have moved to this maneuver, you are going to eliminate a lot of your third-space fluid accumulation.
Dr Tassani. I think there are 2 important factors differing between the groups. First is the shorter exposition to extracorporeal circulation, and second is the lower temperature in the DHCA group, which might have influenced outcome.
Dr Edward D. Verrier (Seattle, Wash). How did you account for such a low bypass time because cooling and warming would necessarily take longer with DHCA? Was it just the ease of repair?
Dr Tassani. As a matter of fact, DHCA makes the surgical repair in most cases easier. Under such conditions, cooling and rewarming took about 20 minutes each, and total bypass time averaged around 40 minutes. The circulatory arrest time was not added to the bypass time. So we had, in this group, 2 bypass periods, one for cooling and one for rewarming. Surgical repair was performed under DHCA conditions. Total CPB time in the LF group was significantly longer, about 80 minutes, which might have influenced the different outcomes in both groups.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. R. Egan, T. L. Butler, A. D. Cole, A. Aharonyan, D. Baines, N. Street, M. Navaratnam, O. Biecker, C. Zazulak, C. G. Au, et al. Myocardial ischemia is more important than the effects of cardiopulmonary bypass on myocardial water handling and postoperative dysfunction: A pediatric animal model. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1265 - 1273.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Eggum, T. Ueland, T. E. Mollnes, V. Videm, P. Aukrust, A. E. Fiane, and H. L. Lindberg Effect of Perfusion Temperature on the Inflammatory Response During Pediatric Cardiac Surgery Ann. Thorac. Surg., February 1, 2008; 85(2): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H Shuhaiber Evaluating the Quality of Trials of Hypothermic Circulatory Arrest Aortic Surgery Asian Cardiovasc Thorac Ann, October 1, 2007; 15(5): 449 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, J. Cai, S. Wang, H. Zhang, J. Liu, Z. Xu, and Z. Su Better protection of pulmonary surfactant integrity with deep hypothermia and circulatory arrest. Ann. Thorac. Surg., July 1, 2006; 82(1): 131 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Schultz, T. Karamlou, J. Swanson, I. Shen, and R. M. Ungerleider Hypothermic Low-Flow Cardiopulmonary Bypass Impairs Pulmonary and Right Ventricular Function More Than Circulatory Arrest Ann. Thorac. Surg., February 1, 2006; 81(2): 474 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ando, I.-S. Park, N. Wada, and Y. Takahashi Steroid Supplementation: A Legitimate Pharmacotherapy After Neonatal Open Heart Surgery Ann. Thorac. Surg., November 1, 2005; 80(5): 1672 - 1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Hanley Religion, politics...deep hypothermic circulatory arrest J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1236 - 1236. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |